Abstract
We describe a comprehensive screening campaign of warheads, linked to a hydroxamate chelating anchor, for the modification of Cys165 within the BoNT/A protease.
Engaging thorough enzyme kinetics, we detail a remarkable proximity-driven
covalent bond with an epoxide warhead, a weak electrophile; yet, one that possessed
superior irreversible inhibition, and pharmacological properties, when compared
to intrinsically higher reactive warheads. This directed, selective covalent
bond was contingent upon the crucial hydroxamate-Zn2+ chelating
interaction as exemplified by examining non-chelating compounds.
We discuss previous approaches using non-target selective cysteine-reactive
warheads to modify the BoNT/A protease of which none present any therapeutic
potential – our bifunctional strategy allows the use of intrinsically less
reactive warheads to intercept the cysteine, which will allow for less
off-target modifications of such inhibitors. Moreover, we also broach that this
bifunctional approach is not a one-off strategy that we believe can be broadly
translated to other metalloproteases that possess non-catalytic, yet, nucleophilic
residues within the enzymes catalytic sphere.